Skylark Bio nabs $40M for hearing loss gene therapy work



The Cambridge startup was incubated by Arch Venture Partners and is led by the founding COO of Agilis Biotherapeutics Inc.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *